IRIS Accounts Production v25.2.0.378 06406479 Board of Directors 1.1.24 31.12.24 31.12.24 29.9.25 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh064064792023-12-31064064792024-12-31064064792024-01-012024-12-31064064792022-12-31064064792023-01-012023-12-31064064792023-12-3106406479ns15:EnglandWales2024-01-012024-12-3106406479ns14:PoundSterling2024-01-012024-12-3106406479ns10:Director12024-01-012024-12-3106406479ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3106406479ns10:SmallEntities2024-01-012024-12-3106406479ns10:Audited2024-01-012024-12-3106406479ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3106406479ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3106406479ns10:FullAccounts2024-01-012024-12-3106406479ns10:OrdinaryShareClass12024-01-012024-12-3106406479ns10:Director22024-01-012024-12-3106406479ns10:Director32024-01-012024-12-3106406479ns10:CompanySecretary12024-01-012024-12-3106406479ns10:RegisteredOffice2024-01-012024-12-3106406479ns5:CurrentFinancialInstruments2024-12-3106406479ns5:CurrentFinancialInstruments2023-12-3106406479ns5:ShareCapital2024-12-3106406479ns5:ShareCapital2023-12-3106406479ns5:RetainedEarningsAccumulatedLosses2024-12-3106406479ns5:RetainedEarningsAccumulatedLosses2023-12-3106406479ns5:PlantMachinery2024-01-012024-12-3106406479ns5:FurnitureFittings2024-01-012024-12-3106406479ns5:ComputerEquipment2024-01-012024-12-3106406479ns5:PlantMachinery2023-12-3106406479ns5:FurnitureFittings2023-12-3106406479ns5:ComputerEquipment2023-12-3106406479ns5:PlantMachinery2024-12-3106406479ns5:FurnitureFittings2024-12-3106406479ns5:ComputerEquipment2024-12-3106406479ns5:PlantMachinery2023-12-3106406479ns5:FurnitureFittings2023-12-3106406479ns5:ComputerEquipment2023-12-3106406479ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3106406479ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3106406479ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 06406479 (England and Wales)















LYNTON CLINICS LIMITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024






LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


LYNTON CLINICS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: J A Exley PhD
Dr A Charlton D.Phil
A J Berry PhD





SECRETARY: A J Berry PhD





REGISTERED OFFICE: Lynton House
Manor Lane
Holmes Chapel
Cheshire
CW4 8AF





REGISTERED NUMBER: 06406479 (England and Wales)





AUDITORS: Clarke Nicklin LLP
Chartered Accountants and
Statutory Auditors
Clarke Nicklin House
Brooks Drive
Cheadle Royal Business Park
Cheadle
Cheshire
SK8 3TD

LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 32,195 23,239

CURRENT ASSETS
Debtors 5 163,001 95,239
Cash at bank 120,293 184,996
283,294 280,235
CREDITORS
Amounts falling due within one year 6 259,699 241,135
NET CURRENT ASSETS 23,595 39,100
TOTAL ASSETS LESS CURRENT
LIABILITIES

55,790

62,339

PROVISIONS FOR LIABILITIES 543 2,553
NET ASSETS 55,247 59,786

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 55,147 59,686
SHAREHOLDERS' FUNDS 55,247 59,786

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by:





J A Exley PhD - Director


LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

Lynton Clinics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in Sterling (£).

Going concern
The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have reached this conclusion giving due consideration to the projected future performance of the company and any potential risk that might impact the company's ability to meet its required solvency levels. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

Significant judgements and estimates
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if revision only affects that period, or in the period of the revision and future periods if the revision affects both current and future periods.

The following judgements have had the most significant effect on amounts recognised in the financial statements:

Depreciation
The useful life of fixed assets can vary significantly. Estimates are based on historic experience and current expectations of useful life. The size of prior year gains and losses on disposal are also factored in to estimates.

Bad debts
The directors regularly review debts and provide for those which are doubtful.

Turnover
Turnover represents net invoiced sales of goods and services, excluding value added tax. Sales are recognised on either date of sale or the date that any treatments were carried out, except in respect of service contracts where sales are recognised when the company obtains the right to consideration.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Clinic equipment - 25% on cost
Fixtures and fittings - 25% on cost
Office equipment - 25% on cost


LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Clinic and Office
equipment fittings equipment Totals
£    £    £    £   
COST
At 1 January 2024 155,381 419 14,161 169,961
Additions 32,880 - - 32,880
Disposals (40,000 ) - - (40,000 )
At 31 December 2024 148,261 419 14,161 162,841
DEPRECIATION
At 1 January 2024 132,142 419 14,161 146,722
Charge for year 7,257 - - 7,257
Eliminated on disposal (23,333 ) - - (23,333 )
At 31 December 2024 116,066 419 14,161 130,646
NET BOOK VALUE
At 31 December 2024 32,195 - - 32,195
At 31 December 2023 23,239 - - 23,239

LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 9,583 30,759
Amounts owed by group undertakings 151,429 64,105
Corporation tax 1,491 -
Prepayments 498 375
163,001 95,239

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 1,705 396
Amounts owed to group undertakings 193,856 193,856
Corporation tax - 5,918
VAT 59,124 38,682
Accruals and deferred income 5,014 2,283
259,699 241,135

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Graham Travis FCA (Senior Statutory Auditor)
for and on behalf of Clarke Nicklin LLP